Revive Therapeutics Moves Closer to a Possible COVID-19 Treatment
Revive Therapeutics Moves Closer to a Possible COVID-19 Treatment On Friday, Revive Therapeutics (OTC: RVVTF) announced that the U.S. Food & Drug Administration has approved the company to conduct a randomized, double-blind, placebo-controlled, Phase-3 clinical...
Aphria’s Massive 84% Q4 Revenue Leap: Is this Marijuana Stock Still a Buy?
Aphria’s Massive 84% Q4 Revenue Leap: Is this Marijuana Stock Still a Buy? In these times of great uncertainty, we’ll take any good news we can get and we were quite pleased to see Aphria’s (NASDAQ: APHA) fourth quarter and fiscal year 2020 results last...
Can Aphria Hold On to its Recent Gains?
Can Aphria Hold On to its Recent Gains? In a year when most pot stocks give investors sleepless nights, there is one specific pot stock that stands out from the crowd. Leamington, Canada-based Aphria (NYSE: APHA) has consistently been profitable and shows no signs of...
GW Pharmaceuticals: High Expectations for this Hemp Stock
GW Pharmaceuticals: High Expectations for this Hemp Stock Despite the ongoing bear market, certain hemp stocks remain attractive due to the rapidly growing global marijuana industry. Most pot stocks are trading significantly lower than their record highs as they have...
Pot Stock Curaleaf Gaining Momentum
Pot Stock Curaleaf Gaining Momentum Curaleaf Holdings (CNSX: CURA), a vertically integrated medical cannabis operator in the US, continues to make headlines as the pot stock gains momentum. This pot stock surged nearly 11% amid news that it has recently acquired...Cannin Monthly Subscription with Trading Alerts
Get advance notice of profitable cannabis & hemp stock trades. Use our machine learning algorithm to start profiting from this explosive industry.
$99 / month after 30-day trial.
Still unsure? Schedule demo at info@cannin.com
or call 720-254-1374